Identity confirmed with an official business registry. How we verify
Acarix AB, based in Sweden, makes the CADScor® System, a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced computational processing to analyze the patient’s coronary blood flow. The system calculates a patient-specific CAD score and combines it with risk factors to rapidly indicate the risk of significant coronary stenosis. CADScor® System is based on 15+ years of R&D, is covered by 45 patents, carries the CE mark under EU MDR 2017/745 and has received FDA De Novo clearance. It has been used in over 60,000 patient assessments.
Description based on the company's website.
Official data
- Registry
- GLEIF
- Number
- 549300KP2XS4513DEI67
- Verified on
Products manufactured
Product illustrations, until the company adds its own photos.
The factor-by-factor breakdown, the comparison of your suppliers and alerts are reserved for buyer accounts. See the details and compare
Request a quote
Contact via Tritonis: the Tritonis team forwards your request to Acarix AB and follows it up until it gets a reply. It also goes right away to the other suppliers ticked below. Indicative forwarding time: 5 business days.
Other suppliers: Electro-medical instruments and apparatus
See all suppliers of this product
Spotted an error on this listing?
Report it: we review every report, usually within two business days. No account is needed.
Contains public sector information licensed under the Open Government Licence v3.0.
Recently viewed

